A paper by Dr Cristina Caffarra and Dr Oliver Latham “Is Antitrust in Need of Disruption: What Is Disruptive Innovation and What, if Anything, Does Competition Policy Need To Do to React to It?” has been published in the Disruptive Technologies – The State of the Debate section of the Italian Antitrust Review.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...